Relative efficacy of prevention counseling with rapid and standard HIV testing: A randomized, controlled trial (RESPECT-2)

Sexually Transmitted Diseases

Volumn 32, Issue 2, 2005, Pages 130-138

  Metcalf, Carol A ^a   Douglas Jr , John M ^b   Malotte, C Kevin ^c   Cross, Helene ^d   Dillon, Beth A ^a   Paul, Sindy M ^d   Padilla, Suzanne M ^c   Brookes, Lesley C ^b   Lindsey, Catherine A ^a   Byers, Robert H ^a   Peterman, Thomas A ^a   Miller, Kenneth ^e   Rietmeijer, Cornelis A ^e   DeAugustine, Nettie ^e   Hollingshead, Judy ^e   Souleles, David M ^e   Parish, LaVeme ^e   Raveneau, Lena M ^e   Frederick, Heather S ^e   Iatesta, Michael ^e   Kamb, Mary L ^e   McKleroy, Vel S ^e   Selman, Laura L ^e   Varghese, Beena ^e   Francis, Robert W ^e   Gordon, Christopher ^e   Signes, Carmen Anita C ^e   Young, Paul A ^e   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DENVER PUBLIC HEALTH   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^e Mailstop E 02 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GONORRHEA; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COUNSELING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; TRICHOMONIASIS;

ADOLESCENT; ADULT; CALIFORNIA; COLORADO; COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEW JERSEY; QUESTIONNAIRES; REAGENT KITS, DIAGNOSTIC; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME;

EID: 19944431506     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000151421.97004.c0     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. HIV Counseling and Testing in Publicly Funded Sites Annual Report 1997 and 1998. Atlanta: US Department of Health and Human Services, 2001.
2. Weinstock H, Dale M, Linley L, et al. Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health 2002; 92:280-283.
3. Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. JAMA 1998; 280:1161-1167.
4. Wiley DJ, Frerichs RR, Ford WL, et al. Failure to learn human immunodeficiency virus test results in Los Angeles public sexually transmitted diseases clinics. Sex Transm Dis 1998; 25:342-345.
5. Tao G, Branson BM, Kassler WJ, et al. Rates of receiving HIV test results: Data from the US National Health Interview Survey for 1994 and 1995. J Acquir Immun Defic Syndr 1999; 22:395-400.
6. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling. AIDS 1997; 11:1045-1051.
7. Valdiserri RO, Moore M, Gerber AR, et al. A study of clients returning for counseling after HIV testing: Implications for improving rates of return. Public Health Rep 1993; 108:12-18.
8. Farnham PG, Gorsky RD, Holtgrave DR, et al. Counseling and testing for HIV prevention: Costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Rep 1996; 3:44-53.
9. Metcalf CA, Malotte CK, Douglas JM, et al. Efficacy of a booster counseling session 6 months after HIV testing and counseling: A randomized controlled trial (RESPECT-2). Sex Transm Dis 2005; 32:123-129.
10. Centers for Disease Control and Prevention. HIV Counseling, Testing, and Referral: Standards and Guidelines. Atlanta: US Department of Health and Human Services, 1994.
11. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Morbid Mortal Wkly Rep 2001; 50(No. RR-19):1-54.
12. Miller WR, Rollnick W. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: The Guilford Press, 1991.
13. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol 1 - The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer, 1980:142-143.
14. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
15. Assmann SF, Pocock SJ, Enos LE, et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355:1064-1069.
16. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. Predictors of sexual behavior patterns over one year among persons at high risk for HIV. Arch Sex Behav 2002; 31:165-176.
17. Cohen DA, MacKinnon DP, Dent C, et al. Group counseling at STD clinics to promote use of condoms. Public Health Rep 1992; 107:727-731.
18. Cohen DA, Dent C, MacKinnon D, et al. Condoms for men, not women: Results of brief promotion programs. Sex Transm Dis 1992; 19:245-251.
19. O'Leary A, Jemmott LS, Goodhart F, et al. Effects of an institutional AIDS prevention intervention: Moderation by gender. AIDS Educ Prev 1996; 8:516-528.
20. St Lawrence JS, Brasfield TL, Jefferson KW, et al. Cognitive-behavioral intervention to reduce African American adolescents' risk for HIV infection. J Consult Clin Psychol 1995; 63:221-237.
21. Semple SJ, Patterson TL, Grant I. Gender differences in sexual risk practices of HIV+ heterosexual men and women. AIDS Behav 2002; 6:45-54.
22. Otten MW Jr, Zaidi AA, Wroten JE, et al. Changes in sexually transmitted disease rates after HIV testing and posttest counseling, Miami, 1988 to 1989. Am J Public Health 1993; 83:529-533.
23. Zenilman JM, Weisman CS, Rampalo AM, et al. Condom use to prevent incident STDs: The validity of self-reported condom use. Sex Transm Dis 1995; 22:15-21.
24. Peterman TA, Lin LS, Newman DR, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Sex Transm Dis 2000; 27:446-451.
25. Fishbein M, Jarvis B. Failure to find a behavioral surrogate for STD incidence - What does it really mean? Sex Transm Dis 2000; 27:452-455.
26. Schachter J. Biologic versus behavioral endpoints - The duet continues [Editorial]. Sex Transm Dis 2000; 27:456-457.
27. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH Multisite HIV Prevention Trial: Reducing HIV sexual risk behavior. Science 1998; 280:1889-1894.
28. Pequegnat W, Fishbein M, Celentano D, et al. NIMH/APPC Workgroup on Behavioral and Biologic Outcomes in HIV/STD Prevention Studies: A position statement. Sex Transm Dis 2000; 27:127-132.
29. Aral SO, Peterman TA. Measuring outcomes of behavioural interventions for STD/HIV prevention. Int J STD AIDS 1996; 7(suppl 2):30-38.
30. Stephenson JM, Imrie J, Sutton SR. Rigorous trials of sexual behavior interventions in STI/HIV prevention: What can we learn from them? AIDS 2000; 14(suppl 3):S115-S124.
31. NIMH Multisite HIV Prevention Trial Group. Endpoints and other measures in a multisite HIV prevention trial: Rationale and psychometric properties. AIDS. 1997; 11(suppl 2):S37-S47.
32. Bolu OO, Lindsey C, Peterman T, et al. Once is not enough: Rescreening sexually transmitted disease patients in six months to detect new, unrecognized STDs. Paper presented at the National STD Prevention Conference; March 4-7, 2002; San Diego, CA.
33. Semaan S, Kay L, Strouse D, et al. A profile of US-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immun Defic Syndr 2002; 30(suppl 1):S30-S50.
34. Bonell C, Imrie J. Behavioral interventions to prevent HIV infection: Rapid evolution, increasing rigour, moderate success. Br Med Bull 2001; 58:155-170.
35. Turner CF, Ku L, Rogers SM, et al. Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science 1998; 280:867-873.
36. Boekeloo BO, Schiavo L, Rabin DL, et al. Self-reports of HIV risk factors by patients at a sexually transmitted disease clinic: Audio vs written questionnaires. Am J Public Health 1994; 84:754-760.
37. Lessler JT, O'Reilly JM. Mode of interview and reporting of sensitive issues: Design and implementation of audio computer-assisted self-interviewing. NIDA Research Monograph 1997; 167:366-382.
38. Kissinger P, Rice J, Parley T, et al. Application of computer-assisted interviews to sexual behavior research. Am J Epidemiol 1999; 149:950-954.
39. Webb PM, Zimet GD, Fortenberry D, et al. Comparability of a computer-assisted versus written method for collecting health behavior information from adolescent patients. J Adolesc Health 1999; 24:383-388.
40. Gribble JN, Miller HG, Rogers SM, et al. Interview mode and measurement of sexual behaviors: Methodological Issues. J Sex Res 1999; 36:16-24.
41. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. Am J Epidemiol 2000; 152:99-106.
42. Johnson AM, Copas AJ, Erens B, et al. Effect of computer-assisted self-interviews on reporting of sexual risk behaviours in a general population sample: A methodological experiment. AIDS 2001; 15:111-115.
43. Newman JC, Des Jarlais DC, Turner CF, et al. The differential effects of face-to-face and computer interview modes. Am J Public Health 2002; 92:294-297.
44. Hitchcock P, Fransen L. Preventing HIV infection: Lessons from Mwanza and Rakai. Lancet 1999; 353:513-515.
45. Grosskurth H, Gray R, Hayes R, et al. Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials. Lancet 2000; 355:1981-1987.
46. Hudson CP. Community-based trials of sexually transmitted disease treatment: Repercussions for epidemiology and HIV prevention. Bull World Health Organ 2001; 79:48-58.
47. Schachter J, Chow JM. The fallibility of diagnostic tests for sexually transmitted diseases: The impact on behavioral and epidemiologic studies. Sex Transm Dis 1995; 22:191-196.
48. Shain RN, Piper JM, Newton ER, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med 1999; 340:93-100.
49. Centers for Disease Control and Prevention. Approval of a new rapid test for HIV antibody. MMWR Morb Mortal Wkly Rep 2002; 51:1051-1052.
50. Centers for Disease Control and Prevention. Advancing HIV prevention: New strategies for a changing epidemic - United States, 2003. MMWR Morbid Mortal WkIy Rep 2003; 52:329-332.
51. Schütz MA, Sandfort TG. HIV-positive people, risk and sexual behaviour. Soc Sci Med 2000; 50:1571-1578.